Pretibial Myxedema

Article Type
Changed
Thu, 01/10/2019 - 13:16
Display Headline
Pretibial Myxedema

Pretibial myxedema (PM) is a cutaneous mucinosis associated with thyroid dysfunction. It most commonly presents in the setting of Graves disease and is seen less often in patients with hypothyroidism and euthyroidism.1 The anterior tibia is most frequently affected, but lesions also may present on the feet, thighs, and upper extremities. Physical examination generally demonstrates skin thickening, hyperkeratosis, hyperpigmentation, yellow-red discoloration, and hyperhidrosis. Classically, the term peau d’orange has been used to characterize these clinical features.1 Histologic examination of PM typically reveals marked deposition of mucin throughout the reticular dermis with sparing of the papillary dermis (Figure 1) and may be accompanied by overlying hyperkeratosis. Collagen fibers are splayed and appear decreased in density (Figure 2). Alcian blue, periodic acid–Schiff, colloidal iron, and toluidine blue staining can be used to highlight dermal mucin.

 

Figure 1. Prominent mucin deposition throughout the reticular dermis in pretibial myxedema (H&E, original magnification ×40).

Figure 2. Increased mucin deposition and collagen fiber splaying in pretibial myxedema (H&E, original magnification ×200).

Figure 3. Scleredema with increased dermal thickness (H&E, original magnification ×20) and interstitial mucin on colloidal iron–stained sections (inset in upper right corner, original magnification ×400).

Figure 4. Scleromyxedema with mucin deposition primarily in the superficial dermis as well as increased cellularity and fibrosis (H&E, original magnification ×200).
 

Figure 5. Nephrogenic systemic fibrosis with prominent mucinous fibrosis (H&E, original magnification ×40).

Figure 6. Tumid lupus erythematosus with a superficial and perivascular lymphoid infiltrate as well as increased dermal mucin (H&E, original magnification ×40).

Similar to PM, histologic examination of scleredema and scleromyxedema usually demonstrate prominent mucin deposition. In scleredema, mucin primarily is visualized in the deep dermis between thick collagen bundles and typically is localized to the back (Figure 3). Scleromyxedema is distinguished by mucin deposition in the superficial dermis with associated fibroblast proliferation and fibrosis (Figure 4).

Nephrogenic systemic fibrosis is characterized by proliferation of CD34+ dermal spindle cells, fibroblasts, interstitial mucin, altered elastic fibers, and thickened collagen bundles that involve the dermis and subcutaneous septa (Figure 5).2 Tumid lupus erythematosus classically demonstrates perivascular and periadnexal superficial and deep lymphocytic inflammation (Figure 6). Similar to scleredema and PM, mucin deposition in tumid lupus erythematosus is interspersed between collagen bundles in the reticular dermis.3

References

 

1. Fatourechi V. Pretibial myxedema: pathophysiology and treatment options. Am J Clin Dermatol. 2005;6:295-309.

2. Cowper SE, Lyndon DS, Bhawan J, et al. Nephro-genic fibrosing dermopathy. Am J Dermatopathol.2001;23:383-393.

3. Kuhn A, Dagmar RH, Oslislo C, et al. Lupus erythematosus tumidus: a neglected subset of cutaneous lupus erythematosus: report of 40 cases. Arch Dermatol. 2000;136:1033-1041.

Article PDF
Author and Disclosure Information

From the University of Iowa Hospitals and Clinics, Iowa City. Drs. Farah and Swick are from the Department of Dermatology. Dr. Swick also is from the Department of Pathology. Ms. Holahan also is from Rutgers New Jersey Medical School, Newark. Dr. Swick also is from the Iowa City VA Health Care System.

The authors report no conflict of interest.

Correspondence: Brian L. Swick, MD, University of Iowa Hospitals and Clinics, Department of Dermatology, 200 Hawkins Dr, Iowa City, IA 52242 ([email protected]).

Issue
Cutis - 94(2)
Publications
Topics
Page Number
60, 73-74
Legacy Keywords
pretibial myxedema, scleredema, nephrogenic systemic fibrosis, dermatopathology, dermpath,
Sections
Author and Disclosure Information

From the University of Iowa Hospitals and Clinics, Iowa City. Drs. Farah and Swick are from the Department of Dermatology. Dr. Swick also is from the Department of Pathology. Ms. Holahan also is from Rutgers New Jersey Medical School, Newark. Dr. Swick also is from the Iowa City VA Health Care System.

The authors report no conflict of interest.

Correspondence: Brian L. Swick, MD, University of Iowa Hospitals and Clinics, Department of Dermatology, 200 Hawkins Dr, Iowa City, IA 52242 ([email protected]).

Author and Disclosure Information

From the University of Iowa Hospitals and Clinics, Iowa City. Drs. Farah and Swick are from the Department of Dermatology. Dr. Swick also is from the Department of Pathology. Ms. Holahan also is from Rutgers New Jersey Medical School, Newark. Dr. Swick also is from the Iowa City VA Health Care System.

The authors report no conflict of interest.

Correspondence: Brian L. Swick, MD, University of Iowa Hospitals and Clinics, Department of Dermatology, 200 Hawkins Dr, Iowa City, IA 52242 ([email protected]).

Article PDF
Article PDF
Related Articles

Pretibial myxedema (PM) is a cutaneous mucinosis associated with thyroid dysfunction. It most commonly presents in the setting of Graves disease and is seen less often in patients with hypothyroidism and euthyroidism.1 The anterior tibia is most frequently affected, but lesions also may present on the feet, thighs, and upper extremities. Physical examination generally demonstrates skin thickening, hyperkeratosis, hyperpigmentation, yellow-red discoloration, and hyperhidrosis. Classically, the term peau d’orange has been used to characterize these clinical features.1 Histologic examination of PM typically reveals marked deposition of mucin throughout the reticular dermis with sparing of the papillary dermis (Figure 1) and may be accompanied by overlying hyperkeratosis. Collagen fibers are splayed and appear decreased in density (Figure 2). Alcian blue, periodic acid–Schiff, colloidal iron, and toluidine blue staining can be used to highlight dermal mucin.

 

Figure 1. Prominent mucin deposition throughout the reticular dermis in pretibial myxedema (H&E, original magnification ×40).

Figure 2. Increased mucin deposition and collagen fiber splaying in pretibial myxedema (H&E, original magnification ×200).

Figure 3. Scleredema with increased dermal thickness (H&E, original magnification ×20) and interstitial mucin on colloidal iron–stained sections (inset in upper right corner, original magnification ×400).

Figure 4. Scleromyxedema with mucin deposition primarily in the superficial dermis as well as increased cellularity and fibrosis (H&E, original magnification ×200).
 

Figure 5. Nephrogenic systemic fibrosis with prominent mucinous fibrosis (H&E, original magnification ×40).

Figure 6. Tumid lupus erythematosus with a superficial and perivascular lymphoid infiltrate as well as increased dermal mucin (H&E, original magnification ×40).

Similar to PM, histologic examination of scleredema and scleromyxedema usually demonstrate prominent mucin deposition. In scleredema, mucin primarily is visualized in the deep dermis between thick collagen bundles and typically is localized to the back (Figure 3). Scleromyxedema is distinguished by mucin deposition in the superficial dermis with associated fibroblast proliferation and fibrosis (Figure 4).

Nephrogenic systemic fibrosis is characterized by proliferation of CD34+ dermal spindle cells, fibroblasts, interstitial mucin, altered elastic fibers, and thickened collagen bundles that involve the dermis and subcutaneous septa (Figure 5).2 Tumid lupus erythematosus classically demonstrates perivascular and periadnexal superficial and deep lymphocytic inflammation (Figure 6). Similar to scleredema and PM, mucin deposition in tumid lupus erythematosus is interspersed between collagen bundles in the reticular dermis.3

Pretibial myxedema (PM) is a cutaneous mucinosis associated with thyroid dysfunction. It most commonly presents in the setting of Graves disease and is seen less often in patients with hypothyroidism and euthyroidism.1 The anterior tibia is most frequently affected, but lesions also may present on the feet, thighs, and upper extremities. Physical examination generally demonstrates skin thickening, hyperkeratosis, hyperpigmentation, yellow-red discoloration, and hyperhidrosis. Classically, the term peau d’orange has been used to characterize these clinical features.1 Histologic examination of PM typically reveals marked deposition of mucin throughout the reticular dermis with sparing of the papillary dermis (Figure 1) and may be accompanied by overlying hyperkeratosis. Collagen fibers are splayed and appear decreased in density (Figure 2). Alcian blue, periodic acid–Schiff, colloidal iron, and toluidine blue staining can be used to highlight dermal mucin.

 

Figure 1. Prominent mucin deposition throughout the reticular dermis in pretibial myxedema (H&E, original magnification ×40).

Figure 2. Increased mucin deposition and collagen fiber splaying in pretibial myxedema (H&E, original magnification ×200).

Figure 3. Scleredema with increased dermal thickness (H&E, original magnification ×20) and interstitial mucin on colloidal iron–stained sections (inset in upper right corner, original magnification ×400).

Figure 4. Scleromyxedema with mucin deposition primarily in the superficial dermis as well as increased cellularity and fibrosis (H&E, original magnification ×200).
 

Figure 5. Nephrogenic systemic fibrosis with prominent mucinous fibrosis (H&E, original magnification ×40).

Figure 6. Tumid lupus erythematosus with a superficial and perivascular lymphoid infiltrate as well as increased dermal mucin (H&E, original magnification ×40).

Similar to PM, histologic examination of scleredema and scleromyxedema usually demonstrate prominent mucin deposition. In scleredema, mucin primarily is visualized in the deep dermis between thick collagen bundles and typically is localized to the back (Figure 3). Scleromyxedema is distinguished by mucin deposition in the superficial dermis with associated fibroblast proliferation and fibrosis (Figure 4).

Nephrogenic systemic fibrosis is characterized by proliferation of CD34+ dermal spindle cells, fibroblasts, interstitial mucin, altered elastic fibers, and thickened collagen bundles that involve the dermis and subcutaneous septa (Figure 5).2 Tumid lupus erythematosus classically demonstrates perivascular and periadnexal superficial and deep lymphocytic inflammation (Figure 6). Similar to scleredema and PM, mucin deposition in tumid lupus erythematosus is interspersed between collagen bundles in the reticular dermis.3

References

 

1. Fatourechi V. Pretibial myxedema: pathophysiology and treatment options. Am J Clin Dermatol. 2005;6:295-309.

2. Cowper SE, Lyndon DS, Bhawan J, et al. Nephro-genic fibrosing dermopathy. Am J Dermatopathol.2001;23:383-393.

3. Kuhn A, Dagmar RH, Oslislo C, et al. Lupus erythematosus tumidus: a neglected subset of cutaneous lupus erythematosus: report of 40 cases. Arch Dermatol. 2000;136:1033-1041.

References

 

1. Fatourechi V. Pretibial myxedema: pathophysiology and treatment options. Am J Clin Dermatol. 2005;6:295-309.

2. Cowper SE, Lyndon DS, Bhawan J, et al. Nephro-genic fibrosing dermopathy. Am J Dermatopathol.2001;23:383-393.

3. Kuhn A, Dagmar RH, Oslislo C, et al. Lupus erythematosus tumidus: a neglected subset of cutaneous lupus erythematosus: report of 40 cases. Arch Dermatol. 2000;136:1033-1041.

Issue
Cutis - 94(2)
Issue
Cutis - 94(2)
Page Number
60, 73-74
Page Number
60, 73-74
Publications
Publications
Topics
Article Type
Display Headline
Pretibial Myxedema
Display Headline
Pretibial Myxedema
Legacy Keywords
pretibial myxedema, scleredema, nephrogenic systemic fibrosis, dermatopathology, dermpath,
Legacy Keywords
pretibial myxedema, scleredema, nephrogenic systemic fibrosis, dermatopathology, dermpath,
Sections
Disallow All Ads
Alternative CME
Article PDF Media

Giant Cell Tumor of the Tendon Sheath

Article Type
Changed
Thu, 01/10/2019 - 13:14
Display Headline
Giant Cell Tumor of the Tendon Sheath

Article PDF
Author and Disclosure Information

Ronda S. Farah, MD; Heather M. Holahan, BA; Brian L. Swick, MD

Issue
Cutis - 93(4)
Publications
Topics
Page Number
174, 181-182
Legacy Keywords
giant cell tumor of the tendon sheath, GCTTS, benign cutaneous neoplasm, hand lesions, giant cell tumor
Sections
Author and Disclosure Information

Ronda S. Farah, MD; Heather M. Holahan, BA; Brian L. Swick, MD

Author and Disclosure Information

Ronda S. Farah, MD; Heather M. Holahan, BA; Brian L. Swick, MD

Article PDF
Article PDF
Related Articles

Issue
Cutis - 93(4)
Issue
Cutis - 93(4)
Page Number
174, 181-182
Page Number
174, 181-182
Publications
Publications
Topics
Article Type
Display Headline
Giant Cell Tumor of the Tendon Sheath
Display Headline
Giant Cell Tumor of the Tendon Sheath
Legacy Keywords
giant cell tumor of the tendon sheath, GCTTS, benign cutaneous neoplasm, hand lesions, giant cell tumor
Legacy Keywords
giant cell tumor of the tendon sheath, GCTTS, benign cutaneous neoplasm, hand lesions, giant cell tumor
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media